Jeremy Grantham acquired 13.1 Thousand Gilead Sciences shares worth $1.28 Million. That's 0.00% of their equity portfolio (384th largest holding). The first Gilead Sciences trade was made in Q1 2013. Since then Jeremy Grantham bought shares 21 more times and sold shares on 21 occasions. The stake costed the investor $872 Thousand, netting the investor a gain of 47% so far.